Tissue type plasminogen activator (tPA) can be effective therapy for embolic stroke by restoring cerebral per fusion. However, a recent experimental study showed that tPA increased infarct size in a mouse model of transient focal isch emia, suggesting a possible adverse effect of tPA on ischemic tissue per se. In this report, the effects of tPA in two rat models of cerebral ischemia were compared. In experiment I, rats were subjected to focal ischemia via injection of autologous clots into the middle cerebral artery territory. Two hours after clot injecti�n, rats were treated with 10 mg/kg tPA or normal saline.
used intraluminally to occlude the origin of the middle cerebral artery. In two groups, the filament was withdrawn after 2 hours to allow for reperfusion, and then rats were randomly treated with 10 mg/kg tP A or normal saline. In the third group, rats were not treated and the filament was not withdrawn so that permanent focal ischemia was present. In this experiment, tP A did not significantly alter lesion volumes after 2 hours of tran sient focal ischemia. In contrast, permanent ischemia signifi cantly increased lesion volumes by 55% compared with tran sient ischemia. These results indicate that in these rat models of focal cerebral ischemia, tPA did not have detectable negative effects. Other potentially negative effects of tPA may be de pendent on choice of animal species and model systems. Key Words: Cerebral ischemia-Excitotoxicity-Hemorrhage Neuroprotection-Reperfusion injury-Thrombolysis. cerebral ischemia. Furthermore, knockout mice that lack the capacity to produce endogenous tP A showed reduced infarct sizes compared with their wild-type littermates (Wang et aI., 1998) .
As tP A is used for the treatment of acute ischemic stroke, it is critical to identify potential neurotoxic effects of this compound. In the present study, we compared the effects of tP A in two different models of focal cerebral ischemia in rats. In experiment 1, the effects of tP A were examined in rats subjected to thromboembolic focal isch emia via injection of autologous clots into the middle cerebral artery territory. In this model, we expected that the thrombolytic properties of tP A would have the pre dominant effects on outcome. In experiment 2, we , ex amined tP A in a mechanical model of arterial occlusion. A standard model was used in which an intraluminal silicon-coated nylon filament is inserted up the internal carotid artery to occlude the origin of the middle cerebral artery. Reperfusion is achieved by withdrawal of the fila ment occluder. In this second experiment, we expected that the potentially neurotoxic effects of tP A could be assessed separately from its thrombolytic properties.
MATERIALS AND METHODS

General methods
Adult male Sprague-Dawley rats were used, following an institutionally approved protocol in accordance with guidelines set by the NIH Guide for the Care and Use of Laboratory Animals. Rats were anesthetized with 1 to 2% halothane under free-breathing conditions in a 2: 1 mixture of air/oxygen. Cath eters were inserted into the femoral artery and vein. Physiologic parameters including rectal core temperature, mean arterial blood pressure, pH, and gases were monitored throughout all experiments. Human recombinant tPA (Activase) was pur chased from Genentech (South San Francisco, CA. U.S.A.).
Animal model for experiment 1
In this experiment, a thromboembolic approach was used to induce focal ischemia in rats (300 to 400 g). A small burr hole was placed into the skull at bregma to serve as a fiducial marker for computed tomography (CT) image localization (see below).
A surgical cutdown was performed via the ventral surface of the neck to expose the internal and external carotid arteries. The external carotid artery, occipital artery, and pterygopalatine ar tery were ligated. A 24-gauge catheter was inserted into the external carotid artery until the tip was positioned at the inter nal carotid junction. Focal ischemia was induced according to methods first described by Kudo et al. (1982) .
Under microsoopic guidance, 200 fLL of autologous micro clot solution was slowly injected into the cerebral circulation to induce focal ischemia. Microclot suspensions were made by passing 48-hour aged clots through a 27-gauge needle three times to ensure that particle sizes were in the 50-fLm range.
Two hours after occlusion, rats were treated with either tPA (10 mg/kg slowly infused intravenously over 30 minutes) or normal saline (n = 8 rats per group).
Animal model for experiment 2
In this experiment, a mechanical method was used to induce focal ischemia in rats (270 to 310 g) via a standard intraluminal approach (Lo et aI., 1998; Zea Longa et aI., 1989) . In brief, a surgical cutdown was performed in the ventral neck region and the internal, external, and common carotid arteries were visu alized. A 4.0 nylon monofilament suture coated with silicon was inserted into the external carotid artery and advanced up the internal carotid artery until the tip was placed -19 to 20 mm from the internal-external carotid bifurcation. After 2 hours of transient focal ischemia, the monofilament suture was with drawn to allow for cerebral reperfusion. Immediately on me chanical reperfusion, rats were given either tPA (10 mg/kg infused over 30 minutes) or normal saline (n = 8 rats per group). A third group of rats (n = 8) were left untreated and subjected to permanent focal ischemia; that is, the filaments were not withdrawn. The purpose of this third group was to establish that maximal ischemic lesions are not achieved after 
Perfusion-sensitive CT scanning
To document the distribution of focal ischemia after throm boembolic occlusions, rats were subjected to perfusion-sensitive CT scanning at -30 to 60 minutes after clot injections to image relative cerebral perfusion. This was necessary to confirm that appropriate occlusions within the middle cerebral artery territories had occurred. Perfusion-sensitive CT was not performed in the second experiment, in which standard and more reproducible mechanical methods of middle cerebral ar tery occlusion were used. Rats were immobilized with a cus tom-made head holder constructed from a lO-mL syringe and scanned in a helical slip-ring CT scanner (TCT 900SX; Toshiba, Tokyo, Japan). Anesthesia was maintained with I to 1.5% halothane in a 2: I air/oxygen mix. Sagittal plane scout images were used to locate the burr hole in the skull at bregma.
Thereafter, an axial slice at the level of bregma was selected, corresponding to the caudate putamen level in rat brain (Paxi nos and Watson, 1982) .
Functional CT scanning was performed using previously de scribed techniques (Hamberg et aI., 1996; Lo et aI., 1996; Shimizu-Sasamata et aI., 1998 (Hamberg et aI., 1996; Lo et aI., 1996; Shimizu-Sasamata et aI., 1998) . This procedure was then repeated after treatment with either normal saline or tP A to assess the profiles of reperfusion.
Quantitative CT imaging data were analyzed as follows.
First, average hemispheric perfusion values were calculated from the contralateral side. Then, a threshold was set at 50% of these contralateral perfusion levels. Ischemic brain areas with perfusion below this 50% threshold were then measured in the ipsilateral hemisphere and expressed as percent area of the ipsilateral side.
Quantitation of ischemic lesion sizes
Rats from both experiments were allowed to recover after ischemic surgery in individual cages. Twenty-four hours later, rats were killed with an overdose of sodium pentobarbital (100 mg/kg intraperitoneally). Brains were extracted, cut into 2-mm thick axial sections, and stained with 2% 2,3,5-triphenyl tetrazolium chloride. Ischemic lesion volumes were quantified using standard computer-assisted image analysis techniques, in which lesion areas from each axial slice were integrated to yield total volumes (Lo et aI., 1998) . To eliminate the effects of brain swelling and edema, an indirect method was used to calculate lesion volumes (Lin et aI., 1993) . The Shapiro-Wilks test for normality was performed and confirmed that data dis tributions were normal. Therefore, parametric two-tailed Stu dent t tests were used to compare results from control rats and tP A-treated rats. P values of <0.05 were considered significant.
RESULTS
In all experiments, systemic parameters (Table I) were within the range expected for halothane-anesthetized rats under free-breathing conditions (Lo et aI., 1998; Memezawa et aI., 1992) . There were no significant dif ferences between control and tPA-treated rats. In experi ment 1, functional CT scans performed between 30 and 60 minutes after clot injection showed that focal isch emia was present primarily within the middle cerebral artery territories (Fig. 1) . In untreated rats, the extent of focal ischemia either worsened or remained unchanged after 2 to 3 hours (Figs. IA and IB). Ischemic brain areas with perfusion below 50% of contralateral hemispheric levels significantly increased (Table 2) . However, in tPA-treated rats, partial restoration of cerebral perfusion was observed (Figs. Ie and ID). After tPA infusion, ischemic brain areas with perfusion below 50% of con tralateral hemispheric levels were significantly decreased ( Table 2) . Twenty-four-hour ischemic lesion sizes were sig nificantly reduced by tPA (50 ± 26 mm3 in tPA-treated rats versus ( 141 ± 42 mm3 in controls, P < 0.05; Fig. 2 ). 7.40 ± 0.03 127 ± 9 40.2 ± 1. 5 36.8 ± 0.6
In experiment 2, mechanically induced focal ischemia and reperfusion resulted in large regions of ischemic in jury localized to the middle cerebral artery territory. To tal lesion volumes in this model were greater than those obtained with the thromboembolic occlusions in experi ment 1. There were no significant differences in 24-hour lesion sizes between control and tPA-treated rats after 2 hours of transient focal ischemia (Fig. 3) . However, per manent occlusion of the middle cerebral artery resulted in lesions that were 55% larger (P < 0.05) than those in the 2-hour occlusion groups (Fig. 3) . 
DISCUSSION
Recently, Wang and colleagues (1998) reported that infusion of tP A significantly increased infarct size in both wild-type and tP A knockout mice after focal cere bral ischemia. Potential negative effects of tPA may be based on its ability to activate plasminogen and induce damaging extracellular proteolytic pathways (Tsirka et ai., 1997a,b). Specifically, nonfibrin substrates for plas min, such as laminin, may be degraded (Chen and Strick land, 1997) , Proteolysis of laminin and other proteins in the extracellular matrix may amplify excitotoxicity. It has been shown that knockout mice deficient in tP A or plasminogen were resistant to excitotoxic injury after intracerebral injections of kainate, N-methyl-D-aspartate, and a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (Tsirka et a!., 1995 (Tsirka et a!., , 1996 (Tsirka et a!., , 1997a . As excitotox icity plays a central role in ischemic pathophysiology (Choi and Rothman, 1990; Lipton and Rosenberg, 1994) , it is conceivable that tP A can have detrimental effects on neuronal survival after stroke.
In the present study, we compared the effects of tPA in two rat models of focal cerebral ischemia. Specifically, we expected that tP A would be neuroprotective in throm boembolic models, whereas in mechanical models of ar terial occlusion, potentially neurotoxic effects of tP A might be examined. Our methodology reproduced results found in prior clinical and animal studies, namely, that tP A effectively restored cerebral perfusion and reduced infarct size. However, we did not find that tP A was neu rotoxic in the mechanical models of arterial occlusion. There were no significant differences in infarct size after ischemia-reperfusion in rats induced by the standard in traluminal occlusion technique. These results stand in contrast to those reported by Wang et ai. (1998) , in which tP A increased infarct volumes after transient focal ischemia produced by similar mechanical methods of arterial occlusion.
There may have been two possible reasons for these different results. First, the doses of human recombinant tP A used were different. In the study by Wang et ai. (1998) , a dose of I mg/kg was used. Here, we used a much higher dose (10 mg/kg) based on the fact that there is a lO-fold difference in fibrin-specific enzyme activity of human recombinant tP A in human versus rodent sys tems (Korninger and Collen, 1981) . However, there is no obvious feason why one would expect neurotoxic effects of tP A to be expressed only at lower rather than higher doses. A second difference lies in the choice of animal species. Wang et ai. (1998) used mouse models of focal ischemia, whereas rat models were used in the present study. Species differences in critical ischemic events have been shown before. For example, rates of DNA damage after ischemia-reperfusion are different in ba boon versus rat (Tagaya et aI., 1997) , and activation pro files of inducible nitric oxide synthase are critically dif ferent in rat versus mouse models of focal ischemia (Yoshida et aI., 1995) . It remains possible that species differences in tP A response after ischemia-reperfusion may explain some of the differences between the results of Wang et ai. (1998) and the present study.
In this study, rats subjected to permanent focal isch emia had significantly larger lesions than those subjected to transient occlusions. This shows that after 2 hours of occlusion, the middle cerebral artery territory is not maximally damaged. This is an important point because if maximal lesions were achieved after 2 hours of tran sient ischemia, then potentially negative effects of tP A would not have been detectable as the lesions would not have been able to get any larger. A related issue worth considering is whether we had sufficient statistical power to detect negative effects of tPA. A standard power analysis of our data (ex = 0.05,13 = 0.8) showed that we would have been able to detect increases of infarction of -40%. This is within the range of expected effects, as in the Wang et ai. study (1998) , tP A increased infarct vol-J Cereb Blood Flow Metab, Vol. 19, No. 12, 1999 umes by 100% in tPA-deficient knockout mice and by 33% in wild-type mice. However, it must be acknowl edged that we would not have been able to reliably detect much smaller changes in infarct size after tP A in our models. Furthermore, as we assess outcomes only at 24 hours, we cannot exclude a role for delayed events. Fi nally, a technical caveat must be emphasized in the pre sent study. The primary purpose of using two different models was to compare a thromboembolic occlusion method against a mechanical one. It has been shown that the intraluminal mechanical occluder does not induce thrombosis in the middle cerebral artery (Zhang et aI., 1995) . However, one cannot unequivocally exclude the possibility that the intraluminal filament might perturb the endothelial surface and induce downstream micro thrombotic events that are not detected.
tP A has been shown to be effective in human clinical trials, but severe complications involving intracerebral hemorrhage occur in some patients (NINDS rt-PA Stroke Study Group, 1997) . Although we did not observe any macroscopic evidence of hemorrhagic transformations in our studies, it is conceivable that, under certain condi tions, tP A may damage the basal lamina and weaken vascular walls after stroke, thus increasing the probabil ity of hemorrhage after reperfusion. Plasmin can cleave and activate matrix metalloproteinases (Mazzieri et aI., 1997 ) that degrade cerebrovascular basal lamina (Heo et aI., 1999; Rosenberg et aI., 1996) . One might speculate that after ischemia, plasminogen activators can exces sively up-regulate these matrix proteinases and lead to alterations in vessel integrity. Furthermore, it is well es tablished in nonhuman primate models of stroke that spontaneous microvascular hemorrhage may play a criti cal role in reperfusion injury (del Zoppo, 1994; Hamman et aI., 1996) . Precise mechanisms that mediate tPA's ex tracellular proteolytic effects after ischemia warrant ad ditional investigation.
In conclusion, our results support prior observations that tP A represents effective therapy for thromboembolic occlusions. In a mechanical model of middle cerebral artery occlusion, however, we did not find evidence of a direct neurotoxic effect of tP A in cerebral tissue. Re ported potentially negative effects of tPA may be criti cally dependent on the choice of animal species and model systems.
Note added in proof: Although no negative effects of tPA were detected in this study of ischemic stroke, a recent paper has demonstrated that tP A significantly amplified hemoglobin induced neurotoxicity in vitro (Wang et aI., 1999) . This raises the important possibility that tPA may have negative effects in hemorrhagic stroke.
